Daptomycin is not active against rapidly growing mycobacteria Free

Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.014274-0
2010-01-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/59/1/135.html?itemId=/content/journal/jmm/10.1099/jmm.0.014274-0&mimeType=html&fmt=ahah

References

  1. Brown-Elliott B. A., Crist C. J., Mann L. B., Wilson R. W., Wallace R. J. Jr 2003; In vitro activity of linezolid against slowly growing nontuberculous mycobacteria. Antimicrob Agents Chemother 47:1736–1738 [CrossRef]
    [Google Scholar]
  2. EUCAST 2008; Miscellaneous antimicrobials – EUCAST clinical MIC breakpoints 2008-06-19 (v 2.2). Retrieved 25/06/09, from http://www.srga.org/eucastwt/MICTAB/MICmiscellaneous.html
  3. Hawkey P. M. 2008; Pre-clinical experience with daptomycin. J Antimicrob Chemother 62 (Suppl. 3):iii7–iii14
    [Google Scholar]
  4. Martin-de-Hijas N. Z., Fernandez-Roblas R., Fernandez-Martínez A. I., Gadea I., Esteban J. 2008; Usefulness of the Etest for studying tigecycline susceptibility of non-pigmented rapidly growing mycobacteria. Int J Antimicrob Agents 32:366–367 [CrossRef]
    [Google Scholar]
  5. Woods G. L., Bergmann J. S., Witebsky F. G., Fahle G. A., Boulet B., Plaunt M., Brown B. A., Wallace R. J. Jr, Wanger A. 2000; Multisite reproducibility of Etest for susceptibility testing of Mycobacterium abscessus , Mycobacterium chelonae , and Mycobacterium fortuitum . J Clin Microbiol 38:656–661
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.014274-0
Loading
/content/journal/jmm/10.1099/jmm.0.014274-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed